Nader Kameli
Assistant professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (9)
Year:
2025
Year:
2025
Year:
2025
Aim: This study aimed to examine the impact of fecal water (FW) of active and remissive Crohn's disease (CD) patients on mucin degradation and epithelial barrier function. Methods: FW and bacterial membrane vesicles (MVs) were isolated from fresh fecal samples of six healthy controls (HCs) and 12 CD patients. Bacterial composition was determined by 16S rRNA gene amplicon sequencing. Results: In vitro FW-induced mucin degradation was higher in CD samples versus HC (p < 0.01), but not associated with specific bacterial genera. FW of three remissive samples decreased transepithelial electrical resistance in Caco-2 cells by 78–87% (p < 0.001). MVs did not induce barrier alterations. Conclusion: The higher mucin-degradation capacity of CD-derived FW might suggest contributions of microbial products to CD pathophysiology.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Plant cells release tiny membranous vesicles called extracellular vesicles (EVs), which are rich in lipids, proteins, nucleic acids, and pharmacologically active compounds. These plant-derived EVs (PDEVs) are safe and easily extractable and have been shown to have therapeutic effects against inflammation, cancer, bacteria, and aging. They have shown promise in preventing or treating colitis, cancer, alcoholic liver disease, and even COVID-19. PDEVs can also be used as natural carriers for small-molecule drugs and nucleic acids through various administration routes such as oral, transdermal, or injection. The unique advantages of PDEVs make them highly competitive in clinical applications and preventive healthcare products in the future. This review covers the latest methods for isolating and characterizing PDEVs, their applications in disease prevention and treatment, and their potential as a new drug carrier, with special attention to their commercial viability and toxicological profile, as the future of nanomedicine therapeutics. This review champions the formation of a new task force specializing in PDEVs to address a global need for rigor and standardization in PDEV research.
Year:
2023
Year:
2023
Collaborators (14)
Ahmed Abdulhaq
Profosor
jazan university
Elham Alsahafi
-
Majid A Darraj
Associate Professor
jazan university
Yasir Mohamed Riza
-
Edrous Alamer
ASSOCIATE PROFESSOR
jazan university
Abdullah Algaissi
jazan university
Daisy MAE Jonkers
Professor
Maastricht University Medical Centre
Abdulaziz H. Alhazmi
jazan university
John Penders
Associate professor
University of Maastricht
Faisal Alzahrani
Full Professor
king abdulaziz university
Mohammad Imran Khan
Senior Scientist
-
Faisal Madkhali
Assistant Professor
jazan university
Ahmed Abdal Dayem
Professor
-
Nizar A Khamjan
Associate Professor
jazan university
Make your next move.
Prepare your application
Review drafts before you send them.